Início › Doença de Crohn › Texas › Tyler
Ensaios clínicos de Doença de Crohn em Tyler, TX
16 estudos para Doença de Crohn estão buscando participantes em locais em Tyler e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RecrutandoFase 3
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
RecrutandoFase 3
- Tyler Research Institute ( Site 5001), Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
RecrutandoFase 2
- Tyler Research Institute /ID# 265545, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 3
- The University of Texas Health Science Center at Tyler, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 2/3
- Tyler Research Institute, LLC, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 2
- Tyler Research Institute, LLC, Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RecrutandoFase 3
- Tyler Research Institute, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 3
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 3
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
RecrutandoFase 2
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
RecrutandoFase 4
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
RecrutandoFase 3
- Tyler Research Institute, LLC, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
RecrutandoFase 3
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
RecrutandoFase 2
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
RecrutandoFase 2
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecrutandoFase 2
- Mirador Therapeutics Selected Site, Tyler
Ensaios de Doença de Crohn em outras cidades
- New York City, NY35 estudos
- Cleveland, OH19 estudos
- St. Louis, MO19 estudos
- Boston, MA19 estudos
- Miami, FL19 estudos
- Orlando, FL17 estudos
- Houston, TX17 estudos
- Atlanta, GA17 estudos
- San Diego, CA15 estudos
- San Antonio, TX15 estudos
- Los Angeles, CA15 estudos
- Philadelphia, PA13 estudos
Outros estudos em Tyler
- Câncer de Pulmão de Não Pequenas Células20 estudos
- Colite ulcerativa14 estudos
- Câncer Colorretal8 estudos
- Insuficiência Cardíaca8 estudos
- Câncer (todos os tipos)7 estudos
- Câncer de Ovário7 estudos
- Câncer Endometrial6 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço6 estudos
- Câncer de Mama6 estudos
- Câncer Metastático5 estudos
- Doença Inflamatória Intestinal5 estudos
- Leucemia Linfocítica Crônica5 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.